Head and Neck Adenocarcinoma — Trials

Head and Neck Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 19
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00068497	Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer	completed	N/A	40	National Cancer Institute (NCI)NIH	1	Jan 14, 2013	clinicaltrials
NCT01510002	Prophylactic Central Neck Dissection for Papillary Thyroid Cancer	completed	N/A	640	Jagiellonian UniversityOTHER	1	Jan 13, 2012	clinicaltrials